Nathan L. Mata Insider Trading Activity
Nathan L. Mata has been net-selling over the last 12 months with 0 purchases and 102 sales across 1 company.
BLTE is the most-traded position with 102 trades. The largest single transaction was a sale of BLTE for $91K on Apr 15, 2026.
Performance Scorecard
Forward stock performance after each transaction by Nathan L. Mata. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +11.0% | 100% | 102 |
| 90 days | — | — | — | — |
| 120 days | — | — | — | — |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersBLTE · BELITE BIO, INC
🔒 Subscribe to see trade entries
Pro members see exactly when Nathan L. Mata bought and sold BLTE.
Upgrade to ProRecent Trades
Showing the 50 most recent of 102 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| May 7, 2026 | BLTE | Sell | 3 | $154.61 | $463.83 | Chief Scientific Officer |
| May 7, 2026 | BLTE | Sell | 226 | $152.45 | $34K | Chief Scientific Officer |
| May 7, 2026 | BLTE | Sell | 428 | $153.56 | $66K | Chief Scientific Officer |
| May 7, 2026 | BLTE | Sell | 9 | $155.25 | $1K | Chief Scientific Officer |
| May 6, 2026 | BLTE | Sell | 240 | $154.41 | $37K | Chief Scientific Officer |
| May 6, 2026 | BLTE | Sell | 8 | $151.57 | $1K | Chief Scientific Officer |
| May 6, 2026 | BLTE | Sell | 128 | $153.42 | $20K | Chief Scientific Officer |
| May 6, 2026 | BLTE | Sell | 100 | $155.97 | $16K | Chief Scientific Officer |
| May 6, 2026 | BLTE | Sell | 424 | $152.67 | $65K | Chief Scientific Officer |
| May 5, 2026 | BLTE | Sell | 121 | $156.53 | $19K | Chief Scientific Officer |
| May 5, 2026 | BLTE | Sell | 173 | $155.48 | $27K | Chief Scientific Officer |
| May 5, 2026 | BLTE | Sell | 68 | $158.11 | $11K | Chief Scientific Officer |
| May 5, 2026 | BLTE | Sell | 120 | $153.92 | $18K | Chief Scientific Officer |
| May 5, 2026 | BLTE | Sell | 363 | $154.44 | $56K | Chief Scientific Officer |
| May 5, 2026 | BLTE | Sell | 155 | $157.29 | $24K | Chief Scientific Officer |
| May 4, 2026 | BLTE | Sell | 236 | $154.24 | $36K | Chief Scientific Officer |
| May 4, 2026 | BLTE | Sell | 32 | $153.50 | $5K | Chief Scientific Officer |
| May 4, 2026 | BLTE | Sell | 172 | $157.49 | $27K | Chief Scientific Officer |
| May 4, 2026 | BLTE | Sell | 235 | $156.57 | $37K | Chief Scientific Officer |
| May 4, 2026 | BLTE | Sell | 325 | $155.21 | $50K | Chief Scientific Officer |
| May 1, 2026 | BLTE | Sell | 52 | $153.89 | $8K | Chief Scientific Officer |
| May 1, 2026 | BLTE | Sell | 23 | $160.00 | $4K | Chief Scientific Officer |
| May 1, 2026 | BLTE | Sell | 82 | $156.24 | $13K | Chief Scientific Officer |
| May 1, 2026 | BLTE | Sell | 38 | $159.08 | $6K | Chief Scientific Officer |
| May 1, 2026 | BLTE | Sell | 65 | $158.35 | $10K | Chief Scientific Officer |
| May 1, 2026 | BLTE | Sell | 106 | $157.45 | $17K | Chief Scientific Officer |
| May 1, 2026 | BLTE | Sell | 346 | $155.48 | $54K | Chief Scientific Officer |
| May 1, 2026 | BLTE | Sell | 288 | $154.38 | $44K | Chief Scientific Officer |
| Apr 30, 2026 | BLTE | Sell | 340 | $157.37 | $54K | Chief Scientific Officer |
| Apr 30, 2026 | BLTE | Sell | 517 | $156.59 | $81K | Chief Scientific Officer |
| Apr 30, 2026 | BLTE | Sell | 101 | $158.15 | $16K | Chief Scientific Officer |
| Apr 30, 2026 | BLTE | Sell | 42 | $155.68 | $7K | Chief Scientific Officer |
| Apr 29, 2026 | BLTE | Sell | 339 | $156.43 | $53K | Chief Scientific Officer |
| Apr 29, 2026 | BLTE | Sell | 22 | $158.19 | $3K | Chief Scientific Officer |
| Apr 29, 2026 | BLTE | Sell | 259 | $155.52 | $40K | Chief Scientific Officer |
| Apr 29, 2026 | BLTE | Sell | 278 | $154.58 | $43K | Chief Scientific Officer |
| Apr 29, 2026 | BLTE | Sell | 102 | $157.39 | $16K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 120 | $160.27 | $19K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 89 | $161.72 | $14K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 53 | $156.61 | $8K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 380 | $159.42 | $61K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 62 | $158.71 | $10K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 222 | $157.49 | $35K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 8 | $155.36 | $1K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 12 | $154.65 | $2K | Chief Scientific Officer |
| Apr 28, 2026 | BLTE | Sell | 54 | $162.14 | $9K | Chief Scientific Officer |
| Apr 27, 2026 | BLTE | Sell | 409 | $163.56 | $67K | Chief Scientific Officer |
| Apr 27, 2026 | BLTE | Sell | 231 | $162.38 | $38K | Chief Scientific Officer |
| Apr 27, 2026 | BLTE | Sell | 280 | $161.62 | $45K | Chief Scientific Officer |
| Apr 27, 2026 | BLTE | Sell | 44 | $160.83 | $7K | Chief Scientific Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| BLTE | BELITE BIO, INC | 102 | $2.7M |
Other insiders at BELITE BIO, INC
2 other tracked filers at BLTE.